MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
convertible notes payable
$3,000K
Proceeds from issuance of
note payable, net
$2,227K
Net cash provided by
financing activities -...
$3,722K
Canceled cashflow
$1,505K
Net cash provided by
financing activities
$3,722K
Repayment of note payable
$1,505K
Decrease in cash and cash
equivalents
$236K
Canceled cashflow
$3,486K
Net cash used in
operating activities
-$3,486K
Impairment loss
$1,263K
Depreciation and
amortization
$1,038K
Amortization of debt discount
$964K
Change in fair value of
derivative liability
-$618K
Other liabilities
$588K
Loss on issuance of
debt
-$480K
Stock-based compensation
expense
$431K
Change in fair value of
warrant liability
$185K
Accounts payable and
accrued expenses
$117K
Accounts receivable
-$21K
Amortization on operating
lease right-of-use...
$17K
Net cash used in
operating activities -...
-$3,486K
Canceled cashflow
$5,722K
Net loss from
continuing operations
-$6,839K
Income tax payable
-$1,083K
Prepaid expenses and
other current assets
$406K
Employee retention tax
credit income
$380K
Debt extinguishment
loss
$220K
Lease liabilities
-$122K
Deferred revenue
-$109K
Accrued diagnostic
services
-$49K
Back
Back
Cash Flow
source: myfinsight.com
ProPhase Labs, Inc. (PRPH)
ProPhase Labs, Inc. (PRPH)